Inogen Valuation
| INGN Stock | USD 7.33 0.17 2.27% |
At this time, the firm appears to be undervalued. Inogen Inc retains a regular Real Value of $8.01 per share. The prevalent price of the firm is $7.33. Our model calculates the value of Inogen Inc from evaluating the firm fundamentals such as Return On Asset of -0.0778, current valuation of 104.58 M, and Return On Equity of -0.19 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Inogen's valuation include:
Price Book 1.1444 | Enterprise Value | Enterprise Value Ebitda (17.60) | Price Sales 0.5927 | Enterprise Value Revenue 0.3115 |
Undervalued
Today
Please note that Inogen's price fluctuation is slightly risky at this time. Calculation of the real value of Inogen Inc is based on 3 months time horizon. Increasing Inogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inogen Stock. However, Inogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.33 | Real 8.01 | Target 10.0 | Hype 7.32 | Naive 7.72 |
The intrinsic value of Inogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Inogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Inogen Inc helps investors to forecast how Inogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inogen more accurately as focusing exclusively on Inogen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Inogen's intrinsic value based on its ongoing forecasts of Inogen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Inogen's closest peers.
Inogen Cash |
|
Inogen Valuation Trend
Knowing Inogen's actual value is paramount for traders when making sound investment determinations. Using both Inogen's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Inogen Total Value Analysis
Inogen Inc is currently forecasted to have valuation of 104.58 M with market capitalization of 198.97 M, debt of 19.41 M, and cash on hands of 223.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Inogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
104.58 M | 198.97 M | 19.41 M | 223.62 M |
Inogen Investor Information
About 81.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inogen Inc recorded a loss per share of 1.52. The entity had not issued any dividends in recent years. Based on the analysis of Inogen's profitability, liquidity, and operating efficiency, Inogen Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Inogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inogen has an asset utilization ratio of 113.34 percent. This suggests that the Company is making $1.13 for each dollar of assets. An increasing asset utilization means that Inogen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Inogen Ownership Allocation
Inogen Inc has a total of 26.53 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. On December 13, 2018, Representative Lamar Smith of US Congress acquired under $15k worth of Inogen Inc's common stock.Inogen Profitability Analysis
The company reported the previous year's revenue of 335.7 M. Net Loss for the year was (35.89 M) with profit before overhead, payroll, taxes, and interest of 154.74 M.About Inogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Inogen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Inogen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Inogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Inogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inogen. We calculate exposure to Inogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inogen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 154.7 M | 120.1 M | |
| Pretax Profit Margin | (0.11) | (0.10) | |
| Operating Profit Margin | (0.13) | (0.12) | |
| Net Loss | (0.11) | (0.10) | |
| Gross Profit Margin | 0.46 | 0.52 |
Inogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 23.7 M | |
| Quarterly Earnings Growth Y O Y | 0.873 |
Inogen Current Valuation Indicators
Inogen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Inogen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Inogen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Inogen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Inogen's worth.When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth 0.055 | Return On Assets |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.